Clinical Data Visualization • March 2026
AmealPeptide®: Natural ACE Inhibition for Blood Pressure Management
Hydrolyzed casein-derived lactotripeptides (VPP & IPP) represent a clinically proven, GRAS-approved approach to cardiovascular health—reducing blood pressure through natural ACE modulation without the side effects of synthetic pharmaceuticals.
AmealPeptide®: Natural ACE Inhibition for Blood Pressure Management
Clinical Data Visualization • Mt. Angel Vitamins • March 2026
The ACE Inhibition Pathway
From milk protein to cardiovascular benefit—how AmealPeptide naturally inhibits the Angiotensin-Converting Enzyme to lower blood pressure.
Blood Pressure Reduction Over 12 Weeks
Change in systolic and diastolic blood pressure over a 12-week supplementation period with AmealPeptide vs. placebo, based on aggregated clinical trial data.
Landmark Trial BP Reductions
Individual clinical trial results showing systolic blood pressure reductions across diverse patient populations. Treatment-naive patients and those with higher baseline BP experienced the greatest benefits.
Comparative ACE Inhibition
In-vitro ACE inhibitory activity of AmealPeptide compared to synthetic ACE inhibitors and placebo. While less potent than pure pharmaceuticals, AmealPeptide provides clinically significant inhibition without adverse effects.
Safety & Tolerability
Unlike standard ACE inhibitors which frequently cause dry cough (up to 20% of patients) and angioedema, clinical trials of AmealPeptide reveal an exceptional safety profile with reported adverse events statistically equivalent to placebo.
Clinical Recommendations
Clinically Validated Efficacy: Consistent daily intake of AmealPeptide significantly reduces both systolic and diastolic blood pressure in individuals with prehypertension and stage 1 hypertension.
Natural Mechanism: The VPP and IPP tripeptides naturally target and inhibit the Angiotensin-Converting Enzyme without introducing synthetic pharmaceutical chemicals.
First-Line Nutraceutical: Given its zero-toxicity profile and GRAS status, AmealPeptide serves as an optimal first-line intervention alongside lifestyle and dietary modifications.
Data visualizations are based on published clinical trial results. For educational purposes. This content does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.